Fresh New Look and Pump Blood: Evaluation of Four Systems (EP Video)
The presentation goal is to demonstrate a new modified technique in processing residual pump blood and thereby reduce the need for blood products and transfusion (22:48 minutes).
Ex Vivo Perfusion of the Heart with an Aim to Increase Viable Hearts for Transplantation (EP Video)
The race is on to develop an affordable, hybridized ex vivo heart perfusion system in which load-independent biventricular contractility and contractile reserve can be measured (26:40 minutes).
TAVR in Private Practice (EP Video)
Having a community based TAVR program opens options for patients in our community where none existed or they had to travel a great distance several times prior to the operation (35:27 minutes).
Open Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)
The regenerative medicine market today includes first of all platelet-rich plasma (PRP) products, brought to market by a large variety of medical companies (52:34 minutes).
Autologous Blood Management Strategies in Cardiac Surgery (EP Video)
In order to minimize the risks and adverse effects after transfusing homologous blood products, new strategies of autologous blood management (ABM) have been introduced in cardiac surgery (45:11 minutes).
Terumo: Optimizing Blood Management (EP Video)
Stephen Roller presents on Terumo's product offerings designed to optimize patient blood management (15:13 minutes).
Emergency Preparedness: Are You Ready? (EP Video)
Failure Mode Effects Analysis, FMEA, is a technique which will help us to be proactive for risk analysis. Perfusion safety will be defined and six steps to perfusion safety will be reviewed. Practical benefits to having a perfusion FMEA will be discussed to see if your perfusion program is ready for an emergency (45:59 minutes).
Cannulation Disaster Management (EP Video)
By understanding the nuances of minimally invasive cardiac surgical perfusion techniques one can hopefully avoid and if necessary successfully navigate most unexpected complications (47:58 minutes).
Hemodynamics in Heart Failure, and the Effects of New Interventions (EP Video)
Heart failure can be the result of a wide range of disorders, including coronary ischemic heart disease, myocardial diseases, and valvular heart disease. Specific treatments address the underlying pathophysiology of the disorder. By reviewing hemodynamic and pressure-volume relationships in disease, we can think about tailoring our therapy to the needs of the patient (46:14 minutes).
IABP Sizing Impact On Augmentation (EP Video)
This presentation aims to address the topic of IAB sizing and its correlation to therapy as well as strategies to optimize size on an individual basis (32:38 minutes).
Starting a Commercial TAVR Program: Important Lessons Learned (EP Video)
This presentation describes the lessons learned from starting a commercial TAVR program in a community-based hospital in Honolulu, HI. (54:49 minutes).
Adults with Congenital Heart Disease: Repeat Offenders (EP Video)
This presentation will help illustrate the marked differences between acquired versus congenital heart disease in the adult population using both case studies and illustrations (60:34 minutes).